Two-Biomarker (IGHV mutational status and FISH cytogenetics) Prognostic Model Predicts Chronic Lymphocytic Leukemia Patient Outcome
This study evaluated a new system for determining the prognosis of patients with chronic lymphocytic leukemia (CLL; N=524) by looking at IGHV and FISH cytogenetics. Low-risk was defined as having mutated IGHV and no adverse FISH cytogenetics, intermediate risk as having either unmutated IGHV or adverse FISH cytogenetics, and high risk as having both. With […]
